Literature DB >> 7635972

Congenital human thyroglobulin defect due to low expression of the thyroid-specific transcription factor TTF-1.

A Acebrón1, P Aza-Blanc, D L Rossi, L Lamas, P Santisteban.   

Abstract

TTF-1 and Pax-8 are thyroid-specific transcription factors, from homeo and paired box genes, respectively, that are responsible for thyroid development and for thyroglobulin and thyroperoxidase gene expression. However, TTF-1 and Pax-8 preferentially bind to the thyroglobulin and thyroperoxidase promoters, respectively. Here, we have studied a patient with defective thyroglobulin synthesis. Thyroglobulin mRNA was found at very low levels while the mRNA for thyroperoxidase was found to be more abundant compared with control tissue. The low levels of thyroglobulin mRNA are caused by a transcriptional defect due to the virtual absence of TTF-1 expression as determined by Northern blot analysis, reverse transcriptase-PCR, and electrophoretic mobility shift assays. The level of Pax-8 mRNA was the same in the goiter and in the control thyroid. These results are the first reported evidence of a congenital goiter with a thyroglobulin synthesis defect due to the low expression of the thyroid-specific transcription factor TTF-1. Moreover, these data suggest that TTF-1 and Pax-8 would be differentially regulating thyroglobulin and thyroperoxidase gene transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635972      PMCID: PMC185263          DOI: 10.1172/JCI118123

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Familial goitre with absence of thyroglobulin and synthesis of thyroid hormones from thyroidal albumin.

Authors:  K B Desai; M N Mehta; M C Patel; S M Sharma; L Ramanna; R D Ganatra
Journal:  J Endocrinol       Date:  1974-03       Impact factor: 4.286

3.  Cloning of human thyroglobulin complementary DNA.

Authors:  H Brocas; D Christophe; V Pohl; G Vassart
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

4.  Molecular cloning of a gene sequence regulated by nerve growth factor.

Authors:  A Levi; J D Eldridge; B M Paterson
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

5.  Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs.

Authors:  S Kimura; T Kotani; O W McBride; K Umeki; K Hirai; T Nakayama; S Ohtaki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  The cAMP response element in the rat thyrotropin receptor promoter. Regulation by each decanucleotide of a flanking tandem repeat uses different, additive, and novel mechanisms.

Authors:  H Shimura; S Ikuyama; Y Shimura; L D Kohn
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

7.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

8.  Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene.

Authors:  D Civitareale; M P Castelli; P Falasca; A Saiardi
Journal:  Mol Endocrinol       Date:  1993-12

9.  An unusually long poly(purine)-poly(pyrimidine) sequence is located upstream from the human thyroglobulin gene.

Authors:  D Christophe; B Cabrer; A Bacolla; H Targovnik; V Pohl; G Vassart
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

10.  Evidence, by in vitro enzymatic iodination of thyroglobulin, that the efficiency of coupling is determined by the initial iodide concentration.

Authors:  L Lamas; P Santisteban; C Turmo; A M Seguido
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

View more
  8 in total

1.  The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium.

Authors:  D Durocher; C Y Chen; A Ardati; R J Schwartz; M Nemer
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 2.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

Review 3.  Stem cells and lung regeneration.

Authors:  Kalpaj R Parekh; Janna Nawroth; Albert Pai; Shana M Busch; Christiana N Senger; Amy L Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2020-08-12       Impact factor: 4.249

4.  Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer.

Authors:  Junji Koyama; Atsushi Horiike; Takahiro Yoshizawa; Yosuke Dotsu; Ryo Ariyasu; Masafumi Saiki; Tomoaki Sonoda; Ken Uchibori; Shingo Nishikawa; Satoru Kitazono; Noriko Yanagitani; Hironori Ninomiya; Yuichi Ishikawa; Makoto Nishio
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

5.  Identification of a novel pax8 gene sequence variant in four members of the same family: from congenital hypothyroidism with thyroid hypoplasia to mild subclinical hypothyroidism.

Authors:  Monica Vincenzi; Marta Camilot; Eleonora Ferrarini; Francesca Teofoli; Giacomo Venturi; Rossella Gaudino; Paolo Cavarzere; Giuseppina De Marco; Patrizia Agretti; Antonio Dimida; Massimo Tonacchera; Attilio Boner; Franco Antoniazzi
Journal:  BMC Endocr Disord       Date:  2014-08-22       Impact factor: 2.763

Review 6.  Application of iPSC to Modelling of Respiratory Diseases.

Authors:  Ben A Calvert; Amy L Ryan Firth
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.

Authors:  Kenji Nakahama; Hiroyasu Kaneda; Masahiko Osawa; Motohiro Izumi; Naoki Yoshimoto; Akira Sugimoto; Hiroaki Nagamine; Koichi Ogawa; Yoshiya Matsumoto; Kenji Sawa; Yoko Tani; Shigeki Mitsuoka; Tetsuya Watanabe; Kazuhisa Asai; Tomoya Kawaguchi
Journal:  Thorac Cancer       Date:  2022-07-08       Impact factor: 3.223

8.  High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism.

Authors:  Nina Makretskaya; Olga Bezlepkina; Anna Kolodkina; Alexey Kiyaev; Evgeny V Vasilyev; Vasily Petrov; Svetlana Kalinenkova; Oleg Malievsky; Ivan I Dedov; Anatoly Tiulpakov
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.